Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Biogen Inc., 1 year.
Biogen Inc.
Director
Caris Life Sciences Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Biogen Inc. June 9, 202699.5%
-
Caris Life Sciences Inc. June 4, 202687.1%
-
Biogen Inc. June 17, 202599.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Caris Life Sciences Inc. | Grant or award | +13,192 | — | — |
| Aug 4, 2026 | Biogen Inc. | Open-market sale | −593 | $200.96 | $119,169 |
| Aug 3, 2026 | Biogen Inc. | Open-market sale | −593 | $203.34 | $120,581 |
| Jun 9, 2026 | Biogen Inc. | Grant or award | +1,505 | — | — |
| Feb 26, 2026 | Caris Life Sciences Inc. | Grant or award | +2,492 | $20.06 | $49,990 |
| Jun 17, 2025 | Biogen Inc. | Grant or award | +2,370 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.